With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine.

With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.

Biotechnology

Education

Tune Therapeutics

Charles A. Gersbach

Jason Dean

Kendra Congdon

Tyler Goodwin

Zachary Hale

Georgeta Puscalau

Katherine H.

Michael P. Hefferan

Derek Jantz

Christina Jordan

Glenn Murphy

Luis Sanchez-Perez

Shannon Grace

Ryan Tam

The Technical Operations and Engineering team at Tune Therapeutics is responsible for advancing the TEMPO epigenomic control platform through innovative engineering and operational excellence. They ensure the seamless integration of bioinformatics, laboratory processes, and non-viral delivery systems, while also developing robust software infrastructure and managing laboratory operations. This multidisciplinary team works collaboratively to optimize experimental workflows, scale up production, and support the translation of cutting-edge research into transformative therapies for complex diseases.

Technical Operations and Engineering

Research and Development

Leadership Team

Technical Operations and Engineering

About

Team members

Other teams at Tune Therapeutics

Research and Development

Leadership Team